TheraRadar
← Back
Data updated: Mar 29, 2026

RISING

CardiovascularNeurologyInfectious Disease
Generics

RISING is a generic drug manufacturer focused on Cardiovascular, Neurology, Infectious Disease.

1958
Since
253
Drugs
-
Trials
2480
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 36%
20 drugs
Neurology 20%
11 drugs
Infectious Disease 16%
9 drugs
Dermatology 16%
9 drugs
Oncology 13%
7 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...